Michael G Fradley (Michael Fradley)

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 20

Top Topics

Oral Anticoagulants

Multiple Myeloma

Atrial Fibrillation

Congenital Heart Disease

Top Venues

Journal of the American Heart Association

European heart journal

Cancer control : journal of the Moffitt Cancer Center

Current oncology reports

This page only lists publications with an associated author ORCID identifier.

Publications

David L DeRemer, Nam H K Nguyen, Avirup Guha, Faraz S Ahmad, Rhonda M Cooper-DeHoff, Carl J Pepine, Michael G Fradley, Yan Gong
Racial and Ethnic Differences in Cardiac Surveillance Evaluation of Patients Treated With Anthracycline-Based Chemotherapy. Journal of the American Heart Association 12 (10) (2023)
David L DeRemer, Nam H K Nguyen, Avirup Guha, Faraz S Ahmad, Rhonda M Cooper-DeHoff, Carl J Pepine, Michael G Fradley, Yan Gong
Racial and Ethnic Differences in Cardiac Surveillance Evaluation of Patients Treated With Anthracycline-Based Chemotherapy. Journal of the American Heart Association (2023)
Michael G Fradley, Nam H K Nguyen, David Madnick, Yiqing Chen, Angela M DeMichele, Igor Makhlin, Susan F Dent, Benedicte Lefebvre, Joseph Carver, Jenica N Upshaw, David L DeRemer, Bonnie Ky, Avirup Guha, Yan Gong
Adverse Cardiovascular Events Associated With Cyclin-Dependent Kinase 4/6 Inhibitors in Patients With Metastatic Breast Cancer. Journal of the American Heart Association (2023)
Marwa Soltani, Lara J Sokoloff, Michael G Fradley
Cardiotoxicities of Non-Chemotherapeutic Metastatic Breast Cancer Treatments. Current oncology reports (2023)
Ahmed Sayed, Malak Munir, Daniel Addison, Abdelrahman I Abushouk, Susan F Dent, Tomas G Neilan, Anne H Blaes, Michael G Fradley, Anju Nohria, Khaled Moustafa, Salim S Virani
The Underutilization of Preventive Cardiovascular Measures in Patients with Cancer. An Analysis of the Behavioural Risk Factor Surveillance System, 2011-2022. European journal of preventive cardiology (2023)
David L DeRemer, Nam H K Nguyen, Avirup Guha, Faraz S Ahmad, Rhonda M Cooper-DeHoff, Carl J Pepine, Michael G Fradley, Yan Gong
Racial and Ethnic Differences in Cardiac Surveillance Evaluation of Patients Treated With Anthracycline-Based Chemotherapy. Journal of the American Heart Association 12 (10) (2023)
David L DeRemer, Nam H K Nguyen, Avirup Guha, Faraz S Ahmad, Rhonda M Cooper-DeHoff, Carl J Pepine, Michael G Fradley, Yan Gong
Racial and Ethnic Differences in Cardiac Surveillance Evaluation of Patients Treated With Anthracycline-Based Chemotherapy. Journal of the American Heart Association 12 (10) (2023)
David L DeRemer, Nam H K Nguyen, Avirup Guha, Faraz S Ahmad, Rhonda M Cooper-DeHoff, Carl J Pepine, Michael G Fradley, Yan Gong
Racial and Ethnic Differences in Cardiac Surveillance Evaluation of Patients Treated With Anthracycline-Based Chemotherapy. Journal of the American Heart Association 12 (10) (2023)
David L Madnick, Michael G Fradley
Atrial Fibrillation and Cancer Patients: Mechanisms and Management. Current cardiology reports 24 (10) (2022)
Avirup Guha, Anubhav Jain, Ankita Aggarwal, Amit K Dey, Sourbha Dani, Sarju Ganatra, Francis E Marchlinski, Daniel Addison, Michael G Fradley
Length of stay and cost of care associated with admissions for atrial fibrillation among patients with cancer. BMC cardiovascular disorders 22 (1) (2022)
Neha Mukunda, Srilakshmi Vallabhaneni, Benedicte Lefebvre, Michael G Fradley
Cardiotoxicity of Systemic Melanoma Treatments. Current treatment options in oncology 23 (2) (2022)
Joerg Herrmann, Daniel J Lenihan, Saro H Armenian, Ana Barac, Anne H Blaes, Daniela Maria Cardinale, Joseph Carver, Susan F Dent, Bonnie Ky, Alexander Richard Lyon, Teresa López Fernández, Michael G Fradley, Sarju Ganatra, Curigliano Giuseppe, Joshua D Mitchell, Giorgio Minotti, Ninian N Lang, Jennifer E Liu, Tomas G Neilan, Anju Nohria, Rupal O'Quinn, Iskra Pusic, Charles Porter, Kerry L Reynolds, Kathryn J Ruddy, Paaladinesh Thavendiranathan, Peter Valent
Defining cardiovascular toxicities of cancer therapies: an International Cardio-Oncology Society (IC-OS) consensus statement. European heart journal 43 (4) (2022)
Lohit Garg, Michael G Fradley
QT prolongation and cancer therapeutics: a coming Tempest or Much Ado About Nothing? European heart journal 42 (38) (2021)
Ohad Oren, Tomas G Neilan, Michael G Fradley, Deepak L Bhatt
Cardiovascular Safety Assessment in Cancer Drug Development. Journal of the American Heart Association 10 (24) (2021)
Avirup Guha, Michael G Fradley, Susan F Dent, Neal L Weintraub, Maryam B Lustberg, Alvaro Alonso, Daniel Addison
Incidence, risk factors, and mortality of atrial fibrillation in breast cancer: a SEER-Medicare analysis. European heart journal (2021)
Michael G Fradley, Allan Welter-Frost, Matthew Gliksman, Josephine Emole, Federico Viganego, Dae Hyun Lee, Bijal Shah, Julio C Chavez, Javier Pinilla-Ibarz, Matthew B Schabath
Electrocardiographic Changes Associated With Ibrutinib Exposure. Cancer control : journal of the Moffitt Cancer Center 27 (1) (2021)
Dae Hyun Lee, Fahad Hawk, Kieun Seok, Matthew Gliksman, Josephine Emole, Isaac B Rhea, Federico Viganego, Allan Welter-Frost, Merna Armanious, Bijal Shah, Juliio C Chavez, Javier Pinilla-Ibarz, Matthew B Schabath, Michael G Fradley
Association between ibrutinib treatment and hypertension. Heart (British Cardiac Society) (2021)
Mohammed Alomar, Michael G Fradley
Electrophysiology Translational Considerations in Cardio-Oncology: QT and Beyond. Journal of cardiovascular translational research 13 (3) (2019)
Michael G Fradley, John D Groarke, Jacob P Laubach, Melissa Alsina, Daniel J Lenihan, Robert Frank Cornell, Michelle Maglio, Kenneth H Shain, Paul Gerard Richardson, Javid Moslehi
Recurrent cardiotoxicity potentiated by the interaction of proteasome inhibitor and immunomodulatory therapy for the treatment of multiple myeloma. British journal of haematology 180 (2) (2017)
Michael G Fradley, Federico Viganego, Kevin Kip, Angel Martin, Aarti A Patel, Roohi Ismail-Khan, Sanders Chae, Bengt Herweg, Arthur Labovitz
Rates and risk of arrhythmias in cancer survivors with chemotherapy-induced cardiomyopathy compared with patients with other cardiomyopathies. Open heart 4 (2) (2017)